COPD Recent Findings: Impact on Clinical Practice

REFERENCES

• Chapman KR, Mannino DM, Soriano JB, Epidemiology and cost of COPD. Eur Respir J 2006; 27:188–207.
   PubMed Web of Science ®Google Scholar
• Agusti A, Soriano JB. COPD as a systemic disease. COPD 2008; 5:133–138.
   PubMedGoogle Scholar
• Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, Mannino D, Wouters E, Sethi S, Cooper CB. COPD as a lung disease with systemic consequences, clinical impacts, mechanisms and potential for early intervention. COPD 2008; 5:235–256.
   PubMedGoogle Scholar
• Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33:1165–1185.
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin J, Casanova C, Montes de Oca M, Mendez R, Pinto-Plata V, Cabral H. The body mass-index, airflow obstruction, dyspnea and exercise capacity index in COPD. N Engl J Med 2004; 350:1005–1012.
   PubMed Web of Science ®Google Scholar
• Coronell C, Orozco-Levi M, Méndez R, Ramírez-Sarmiento A, Gáldiz JB, Gea J. Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J 2004; 24:129–136.
   PubMed Web of Science ®Google Scholar
• Allaire J, Maltais F, Doyon JF, Noel M, Leblanc P, Carrier G, Simard C, Jobin J. Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax 2004; 59:673–678.
   PubMed Web of Science ®Google Scholar
• Couillard A, Koechlin C, Cristol JP, Varray A, Prefaut Ch. Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients. Eur Respir J 2002; 20:1–7.
   PubMedGoogle Scholar
• Van't hul A, Harllar J, Gosselink R, Hollander P, Postmus P, Kwakkel G. Quadriceps muscle endurance in patients with chronic obstructive pulmonary disease. Muscle Nerve 2004; 29:267–274.
   PubMed Web of Science ®Google Scholar
• Gagnon P, Saey D, Vivodtzev I, Laviolette L, Mainguy V, Milot J, Provencher S, Maltais F. Impact of pre-induced quadriceps fatigue on exercise response in chronic obstructive pulmonary disease and healthy subjects. J Appl Physiol 2009 Jul 2. [Epub ahead of print).
   PubMedGoogle Scholar
• Gosker H, Zeegers M, Wouters E, Schols A. Muscle fiber type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax 2007; 62:944–949.
   PubMed Web of Science ®Google Scholar
• Swallow E, Reyes D, Hopkinson N, Man W, Porcher R, Cetti E, Moore A, Moxham J, Polkey M. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007; 62:115–120.
   PubMed Web of Science ®Google Scholar
• Vilaro J, Rabinovich R, Gonzalez-deSuso JM, Troosters T, Rodríguez D, Barberà JA, Roca J. Clinical assessment of peripheral muscle function in patients with chronic obstructive pulmonary disease. Am J Phys Med Rehabil 2009; 88:39–46.
   PubMed Web of Science ®Google Scholar
• Man WD, Soliman MG, Nikoletou D, Harris ML, Rafferty GF, Mustfa N, Polkey MI, Moxham J. Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. Thorax 2003; 58:665–669.
   PubMed Web of Science ®Google Scholar
• Couillard A, Prefaut C. From muscle disuse to myopathy in patients with COPD: potential contribution of oxidative stress. Eur Respir J 2005; 26:703–719.
   PubMed Web of Science ®Google Scholar
• Schols AMWJ, Soeters PB, Dingemans MC, Mostert R, Frantzen PJ, Wouters EFM. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147:1151–1156.
   PubMed Web of Science ®Google Scholar
• Creutzberg EC, Schols AM, Bothmer-Quaedvlieg FC, Wouters EF. Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function. Eur J Clin Nutr 1998; 52:396–401.
   PubMed Web of Science ®Google Scholar
• Schols AMWJ, Mostert R, Soeters PB, Saris WHM, Wouters EFM. Energy balance in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 143:1248–1252.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, Sørensen TI, Lange P. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006; 173:79–83.
   PubMed Web of Science ®Google Scholar
• Ischaki E, Papatheodorou G, Gaki E, Papa I, Koulouris N, Loukides S. Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest 2007; 132:164–169.
   PubMed Web of Science ®Google Scholar
• Remels AH, Gosker HR, Van Der Velden J, Langen RC, Schols AM. Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease: state of the art and novel insights in regulation of muscle plasticity. Clin Chest Med 2007; 28:537–552.
   PubMed Web of Science ®Google Scholar
• Cano NJ, Roth H, Court-Ortuné I, Cynober L, Gérard-Boncompain M, Cuvelier A, Laaban JP, Melchior JC, Pichard C, Raphaël JC, Pison CM. Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation. Eur Respir J 2002; 20:30–37.
   PubMed Web of Science ®Google Scholar
• Creutzberg EC, Casaburi R. Endocrinological disturbances in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003; 46:76s–80s.
   PubMedGoogle Scholar
• Dimopoulou I, Ilias I, Mastorakos G, Mantzos E, Roussos C, Koutras DA. Effects of severity of chronic obstructive pulmonary disease on thyroid function. Metabolism 2001; 50:1397–1401.
   PubMed Web of Science ®Google Scholar
• Kamischke A, Kemper DE, Castel MA, Luthke M, Rolf C, Behre HM, Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J 1998; 11:41–45.
   PubMed Web of Science ®Google Scholar
• Debigare R, Marquis K, Cote CH, Tremblay RR, Michaud A, Leblanc P, Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 2003; 124:83–89.
   PubMed Web of Science ®Google Scholar
• Scalvini S, Volterrani M, Vitacca M, Clark AL, Solfrini R, Panzali AM, Ferrari R, Levi GF. Plasma hormone levels and haemodynamics in patients with chronic obstructive lung disease. Monaldi Arch Chest Dis 1996; 51:380–386.
   PubMedGoogle Scholar
• John M, Lange A, Hoernig S, Witt C, Anker SD. Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. Int J Cardiol 2006; 111:365–370.
   PubMed Web of Science ®Google Scholar
• Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007; 29:923–929.
   PubMed Web of Science ®Google Scholar
• Chambellan A, Chailleux E, Similowski T; ANTADIR Observatory Group. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 2005; 128:1201–1208.
   PubMed Web of Science ®Google Scholar
• John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD. Anemia and inflammation in COPD. Chest 2005; 127:825–829.
   PubMed Web of Science ®Google Scholar
• Schönhofer B, Wenzel M, Geibel M, Köhler D. Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease. Crit Care Med 1998; 26:1824–1828.
   PubMed Web of Science ®Google Scholar
• Graat-Verboom L, Wouters EF, Smeenk FW, Van Den Borne BE, Lunde R, Spruit MA. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J 2009; 34:209–218.
   PubMed Web of Science ®Google Scholar
• Jørgensen NR, Schwarz P. Osteoporosis in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 2008; 14:122–127.
   PubMed Web of Science ®Google Scholar
• Vrieze A, de Greef MH, Wijkstra PJ, Wempe JB. Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos Int 2007; 18:1197–1202.
   PubMed Web of Science ®Google Scholar
• Janssens W, Lehouck A, Carremans C, Bouillon R, Mathieu C, Decramer M. Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med 2009; 179:630–636.
   PubMed Web of Science ®Google Scholar
• Graat-Verboom L, Spruit MA, Van Den Borne BE, Smeenk FW, Martens EJ, Lunde R, Wouters EF, CIRO Network. Correlates of osteoporosis in chronic obstructive pulmonary disease: An underestimated systemic component. Respir Med 2009; 103:1143–1151.
   PubMed Web of Science ®Google Scholar
• Ferguson GT, Calverley PM, Anderson JA, Jenkins CR, Jones PW, Willits LR, Yates JC, Vestbo J, Celli B. Prevalence and progression of osteoporosis in patients with COPD. Results from TORCH Chest 2009 Jul 6. [Epub ahead of print]
   Google Scholar
• Putman-Casdorph H, McCrone S. Chronic obstructive pulmonary disease, anxiety, and depression: state of the science. Heart Lung 2009; 38:34–47.
   PubMed Web of Science ®Google Scholar
• Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, Hanania NA; ACCP Workshop Panel on Anxiety and Depression in COPD. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008; 134:43S–56S.
   PubMed Web of Science ®Google Scholar
• Hynninen KM, Breitve MH, Wiborg AB, Pallesen S, Nordhus IH. Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res 2005; 59:429–443.
   PubMed Web of Science ®Google Scholar
• Gudmundsson G, Gislason T, Janson C, Lindberg E, Suppli Ulrik C, Brøndum E, Nieminen MM, Aine T, Hallin R, Bakke P. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med 2006; 100:87–93.
   PubMed Web of Science ®Google Scholar
• McCathie HC, Spence SH, Tate RL. Adjustment to chronic obstructive pulmonary disease: the importance of psychological factors. Eur Respir J 2002; 19:47–53.
   PubMed Web of Science ®Google Scholar
• Hill K, Geist R, Goldstein RS, Lacasse Y. Anxiety and depression in end-stage COPD. Eur Respir J 2008; 31:667–677.
   PubMed Web of Science ®Google Scholar
• Norwood RJ. A review of etiologies of depression in COPD. Int J Chron Obstruct Pulmon Dis 2007; 2:485–491.
   PubMedGoogle Scholar
• Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly patients with chronic obstructive pulmonary disease. Age Ageing 2006; 35:457–459.
   PubMed Web of Science ®Google Scholar
• Al-Shair K, Dockry R, Mallia-Milanes B, Kolsum U, Singh D, Vestbo J. Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med 2009 Jun 25 [Epub ahead of print].
   PubMedGoogle Scholar
• Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32:962–969.
   PubMed Web of Science ®Google Scholar
• Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003; 52:812–817.
   PubMed Web of Science ®Google Scholar
• Marquis K, Maltais F, Duguay V, Bezeau AM, LeBlanc P, Jobin J, Poirier P. The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2005; 25:226–232.
   PubMedGoogle Scholar
• Fabbri LM, Luppi F, Beghé B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J 2008; 31:204–212.
   PubMed Web of Science ®Google Scholar
• Watz H, Waschki B, Kirsten A, Müller KC, Kretschmar G, Meyer T, Holz O, Magnussen H. The Metabolic syndrome in patients with chronic bronchitis and COPD: Frequency and associated consequences for systemic inflammation and physical inactivity. Chest 2009 Jun 19. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005; 128:2640–2646.
   PubMed Web of Science ®Google Scholar
• Rutten FH, Cramer MJ, Lammers JW, Grobbee DE, Hoes AW. Heart failure and chronic obstructive pulmonary disease: An ignored combination? Eur J Heart Fail 2006; 8:706–711.
   PubMed Web of Science ®Google Scholar
• Thurnheer R, Muntwyler J, Stammberger U, Bloch KE, Zollinger A, Weder W, Russi EW. Coronary artery disease in patients undergoing lung volume reduction surgery for emphysema. Chest 1997; 112:122–118.
   PubMed Web of Science ®Google Scholar
• Marquis K, Maltais F, Poirier P. Cardiovascular manifestations in patients with COPD. Rev Mal Respir 2008; 25:663–673.
   PubMed Web of Science ®Google Scholar
• Kleiger RE, Senior RM. Longterm electrocardiographic monitoring of ambulatory patients with chronic airway obstruction. Chest 1974;65:483–487.
   Google Scholar
• Weitzenblum E, Kessler R, Oswald M, Fraisse P. Medical treatment of pulmonary hypertension in chronic lung disease. Eur Respir J 1994; 7:148–152.
   PubMed Web of Science ®Google Scholar
• Burger CD. Pulmonary hypertension in COPD: a review and consideration of the role of arterial vasodilators. COPD 2009; 6:137–144.
   PubMedGoogle Scholar
• Thabut G, Dauriat G, Stern JB, Logeart D, Lévy A, Marrash-Chahla R, Mal H. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005; 127:1531–1536.
   PubMed Web of Science ®Google Scholar
• Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst 2006; 98:691–699.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Aguayo SM, Petty TL, Redd SC. Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med 2003; 163:1475–1480.
   PubMed Web of Science ®Google Scholar
• Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313:711–715.
   PubMed Web of Science ®Google Scholar
• Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer. Am J Respir Crit Care Med 1990; 141:613–617.
   PubMed Web of Science ®Google Scholar
• Islam SS, Schottenfeld D. Declining FEV1 and chronic productive cough in cigarette smokers: a 25 year prospective study of lung cancer incidence in Tecumseh, Michigan. Cancer Epidemiol Biomarkers Prev 1994; 3:289–298.
   PubMed Web of Science ®Google Scholar
• Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 2007; 176:285–290.
   PubMed Web of Science ®Google Scholar
• Wasswa-Kintu S, Gan WQ, Man SF, Pare PD, Sin DD. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 2005; 60:570–575.
   PubMed Web of Science ®Google Scholar
• Formiga F, Lopez-Soto A, Masanes F, Chivite D, Sacanella E, Pujol R. Influence of acute exacerbation of chronic obstructive pulmonary disease or congestive heart failure on functional decline after hospitalization in nonagenarian patients. Eur J Intern Med 2005; 16:24–28.
   PubMedGoogle Scholar
• Almagro P, Calbo E, Ochoa de Echaguen A, Mortality after hospitalization for COPD. Chest 2002; 121:1441–1448.
   PubMed Web of Science ®Google Scholar
• Rozzini R, Sabatini T, Cassinadri A, Boffelli S, Ferri M, Barbisoni P, Frisoni GB, Trabucchi M. Relationship between functional loss before hospital admission and mortality in elderly persons with medical illness. J Gerontol A Biol Sci Med Sci 2005; 60:1180–1183.
   PubMed Web of Science ®Google Scholar
• Minicuci N, Maggi S, Noale M, Predicting mortality in older patients. The VELCA Study. Aging Clin Exp Res 2003; 15:328–335.
   PubMed Web of Science ®Google Scholar
• Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167:544–549.
   PubMed Web of Science ®Google Scholar
• Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004; 23:28–33.
   PubMed Web of Science ®Google Scholar
• Takigawa N, Tada A, Soda R, Date H, Yamashita M, Endo S, Takahashi S, Kawata N, Shibayama T, Hamada N, Sakagucchi M, Hirano A, Kimura G, Okada C, Takahashi K. Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients. Respir Med 2007; 1001:561–567.
   Google Scholar
• Casanova. C, Cote C, Marin JM, Pinto-Plata V, De Torres JP, Aguirre-Jaime A, Vassaux C, Celli BR. Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest 2008; 134:746–752.
   PubMed Web of Science ®Google Scholar
• Panos RJ, Eschenbacher W. Exertional desaturation in patients with chronic obstructive pulmonary disease. COPD 2009; 6:478–487.
   PubMedGoogle Scholar
• Pitta F, Troosters T, Spruit MA, Decramer M, Gosselink R. Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2005; 86: 1979–1985.
   PubMed Web of Science ®Google Scholar
• Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. Eur Respir J 2009; 33:262–272.
   PubMed Web of Science ®Google Scholar
• Pitta F, Troosters T, Spruit MA, Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171:972–977.
   PubMed Web of Science ®Google Scholar
• Garcia-Aymerich J, Serra I, Gómez FP, Farrero E, Balcells E, Rodríguez DA, de Batlle J, Gimeno E, Donaire-Gonzalez D, Orozco-Levi M, Sauleda J, Gea J, Rodriguez-Roisin R, Roca J, Agustí AG, Antó JM. Physical activity and clinical and functional status in COPD. Chest 2009; 136:62–70.
   PubMed Web of Science ®Google Scholar
• Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006; 61:772–778.
   PubMed Web of Science ®Google Scholar
• Garcia-Aymerich J, Farrero E, Félez MA, Izquierdo J, Marrades RM, Antó JM; Estudi del Factors de Risc d'Agudització de la MPOC investigators. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58:100–105.
   PubMed Web of Science ®Google Scholar
• Marquis K, Debigaré R, Lacasse Y, Leblanc P, Jobin J, Carrier G, Maltais F. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with COPD. Am J Resp Crit Care Med 2002; 166:809–813.
   PubMed Web of Science ®Google Scholar
• Esteban C, Quintana JM, Aburto M, Moraza J, Egurrola M, España PP, Pérez-Izquierdo J, Capelastegui A. Predictors of mortality in patients with stable COPD. J J Gen Intern Med J 2008; 23:1829–1834.
   PubMed Web of Science ®Google Scholar
• Antonelli-Incalzi R, Pedone C, Scarlata S, Battaglia S, Scichilone N, Forestiere F, Bellia V. Correlates of mortality in elderly COPD patients: focus on health-related quality of life. Respirology 2009; 14:98–104.
   PubMed Web of Science ®Google Scholar
• Conte ME, Pedone C, Forastiere F, Bellia V, Antonelli-Incalzi R. Discriminative and predictive properties of disease-specific and generic health status indexes in elderly COPD patients. BMC Pulm Med 2008; 8:14.
   PubMedGoogle Scholar
• Halpin DM, Peterson S, Larsson TP, Calverley PM. Identifying COPD patients at increased risk of mortality: predictive value of clinical study baseline data. Respir Med 2008; 102:1615–1624.
   PubMed Web of Science ®Google Scholar
• Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, Alonso J, Félez M, Khalaf A, Marrades RM, Monsó E, Serra-Batlles J, Antó JM. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166:680–685.
   PubMed Web of Science ®Google Scholar
• Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T, Izumi T. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999; 116:1632–1637.
   PubMed Web of Science ®Google Scholar
• Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121:1434–1440.
   PubMed Web of Science ®Google Scholar
• Schembri S, Anderson W, Morant S, Winter J, Thompson P, Pettitt DM, Macdonald TH, Winter J. A predictive model of hospitalisation and death from chronic obstructive pulmonary disease. Respir Med 2009; Jun 8. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Tsimogianni AM, Papiris SA, Stathopoulos GT, Manali ED, Roussos C, Kotanidou A. Predictors of outcome after exacerbation of chronic obstructive pulmonary disease. J Gen Intern Med 2009; Jul 14. [Epub ahead of print].
   PubMedGoogle Scholar
• Celli BR, Cote CG, Lareau SC, Meek PM. Predictors of survival in COPD: more than just the FEV1. Respir Med 2008; 102 Suppl 1:S27–S35.
   PubMed Web of Science ®Google Scholar
• Marin JM, Carrizo SJ, Casanova C, Martinez-Camblor P, Soriano JB, Agusti AG, Celli BR. Prediction of risk of COPD exacerbations by the BODE index. Respir Med 2009; 103:373–378.
   PubMed Web of Science ®Google Scholar
• Medinas Amorós M, Mas-Tous C, Renom-Sotorra F, Rubí-Ponseti M, Centeno-Flores MJ, Gorriz-Dolz MT. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index. Chron Respir Dis 2009; 6:75–80.
   PubMedGoogle Scholar
• Funk GC, Kirchheiner K, Burghuber OC, Hartl S. BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD—A cross-sectional study. Respir Res 2009; 10:1.
   PubMed Web of Science ®Google Scholar